光威復材(300699.SZ):威海拓展與內蒙古光威簽訂技術許可合同
格隆匯3月18日丨光威復材(300699.SZ)公佈,公司全資子公司威海拓展纖維有限公司(簡稱“威海拓展”)與控股子公司內蒙古光威碳纖有限公司(簡稱“內蒙古光威”)於2024年3月18日簽署了《技術許可合同》,威海拓展許可內蒙古光威使用T700級、T800級、T1000級碳纖維等相關技術,內蒙古光威支付相應的技術使用費。
內蒙古光威由公司全資子公司威海光威能源新材料有限公司(簡稱“光威能源”)和公司控股股東威海光威集團有限責任公司(簡稱“光威集團”)共同出資設立,光威能源持有內蒙古光威60%股權,光威集團持有內蒙古光威40%股權,內蒙古光威為公司控股子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.